Metropolis Healthcare Limited (NSE:METROPOLIS) — Market Cap & Net Worth

$328.65 Million USD · Rs30.39 Billion INR · Rank #14480

Market Cap & Net Worth: Metropolis Healthcare Limited (METROPOLIS)

Metropolis Healthcare Limited (NSE:METROPOLIS) has a market capitalization of $328.65 Million (Rs30.39 Billion) as of September 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #14480 globally and #723 in its home market, demonstrating a 0.70% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Metropolis Healthcare Limited's stock price Rs586.30 by its total outstanding shares 51831942 (51.83 Million). Also see total assets of Metropolis Healthcare Limited for a full breakdown of the balance sheet.

Metropolis Healthcare Limited Market Cap History: 2019 to 2026

Metropolis Healthcare Limited's market capitalization history from 2019 to 2026. Data shows change from $796.79 Million to $328.65 Million (-6.15% CAGR). Also see Metropolis Healthcare Limited operating cash flow efficiency for how efficiently the company converts equity into cash flow.

Index Memberships

Metropolis Healthcare Limited is a constituent of 5 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.06 Trillion	0.01%	#393 of 500
NIFTY HEALTHCARE NIFTYHEALTHCARE	$119.57 Billion	0.27%	#13 of 20
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.14 Trillion	0.03%	#315 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.15 Trillion	0.01%	#526 of 750
NIFTY SMALLCAP 250 NISM250	$406.30 Billion	0.08%	#205 of 250

Weight: Metropolis Healthcare Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Metropolis Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Metropolis Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Metropolis Healthcare Limited (METROPOLIS) stock price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.08x

Metropolis Healthcare Limited's market cap is 0.08 times its annual revenue

Industry average: 0.64x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.75x

Metropolis Healthcare Limited's market cap is 0.75 times its annual earnings

Industry average: 2.32x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2019	$796.79 Million	$7.61 Billion	$1.20 Billion	0.10x	0.66x
2020	$1.08 Billion	$8.56 Billion	$1.27 Billion	0.13x	0.85x
2021	$1.90 Billion	$9.98 Billion	$1.83 Billion	0.19x	1.04x
2022	$737.86 Million	$12.28 Billion	$2.14 Billion	0.06x	0.34x
2023	$940.67 Million	$11.48 Billion	$1.43 Billion	0.08x	0.66x
2024	$1.16 Billion	$12.08 Billion	$1.28 Billion	0.10x	0.91x
2025	$1.08 Billion	$13.31 Billion	$1.45 Billion	0.08x	0.75x

Competitor Companies of METROPOLIS by Market Capitalization

Companies near Metropolis Healthcare Limited in the global market cap rankings as of September 19, 2026. Review Metropolis Healthcare Limited tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Metropolis Healthcare Limited by market ranking:

Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
Danaher Corporation (NYSE:DHR): Ranked #160 globally with a market cap of $150.10 Billion USD.
WuXi AppTec Co Ltd (SHG:603259): Ranked #470 globally with a market cap of $58.08 Billion USD ( CN¥396.94 Billion CNY).
Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#89	Thermo Fisher Scientific Inc	NYSE:TMO	$224.59 Billion	$658.32
#160	Danaher Corporation	NYSE:DHR	$150.10 Billion	$212.50
#470	WuXi AppTec Co Ltd	SHG:603259	$58.08 Billion	CN¥160.49
#577	Natera Inc	NASDAQ:NTRA	$47.01 Billion	$366.31

Metropolis Healthcare Limited Historical Marketcap From 2019 to 2026

Between 2019 and today, Metropolis Healthcare Limited's market cap moved from $796.79 Million to $ 328.65 Million, with a yearly change of -6.15%.

Year	Market Cap	Change (%)
2026	Rs328.65 Million	-69.60%
2025	Rs1.08 Billion	-7.11%
2024	Rs1.16 Billion	+23.75%
2023	Rs940.67 Million	+27.49%
2022	Rs737.86 Million	-61.27%
2021	Rs1.90 Billion	+76.17%
2020	Rs1.08 Billion	+35.71%
2019	Rs796.79 Million	--

End of Day Market Cap According to Different Sources

On Sep 18th, 2026 the market cap of Metropolis Healthcare Limited was reported to be:

Source	Market Cap
Yahoo Finance	$328.65 Million USD
MoneyControl	$328.65 Million USD
MarketWatch	$328.65 Million USD
marketcap.company	$328.65 Million USD
Reuters	$328.65 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research

Market Cap

$328.65 Million

Rs30.39 Billion INR

Market Cap Rank

#14480 Global

#723 in India

Share Price

Rs586.30

Change (1 day)

+0.94%

52-Week Range

Rs421.75 - Rs2133.60

All Time High

Rs3431.71